维普期刊资源整合服务平台（V6.5）

373篇 您的检索式：作者名="Schally"

选中清除导出查看参考文献查看引证文献引用追踪共19页首页上一页第1页下一页末页 /19 跳转

	题名	作者	年代	出处	被引量
1	Targeted therapy in advanced metastatic colorectal cancer: Current concepts and perspectives显示文摘The introduction of new cytotoxic substances as well as agents that target vascular endothelial growth factor(VEGF)and epidermal growth factor receptor(EGFR)signaling has improved clinical outcome of patients withmetastatic colorectal cancer(mCRC).In this review we summarize the most relevant clinical data on VEGF and EGFR targeting regimens in mCRC.The effects of available treatment strategies for mCRC are often temporary,with resistance and disease progression developing in most patients.Thus,new treatment strategies are urgently needed.Some GI peptides including gastrin and gastrin releasing peptide,certain growth factors such as insulin-like growth factor-ⅠandⅡand neuropeptides such as growth hormone releasing hormone(GHRH)are implicated in the growth of CRC.Experimental investigations in CRC with antagonistic analogs of bombesin/gastrin-releasing peptide,GHRH,and with cytotoxic peptides that can be targeted to peptide receptors on tumors,are summarized in the second part of the review.	Florian Hohla Thomas Winder Richard Greil Ferenc G Rick Norman L Block rew V Schally	2014	World Journal of Gastroenterology2014，20，20：	3
2	Mechanisms of antineplastic action of somatostatin analogs显示文摘	Pollak MN Schally AV	1998	Proc Soc Exp Biol Med1998，217，2：	2
3	Inhibitory effects of antagonists of bombesin/gastrin releasing peptide ( GRP ) and somatostatin analog ( RC160) on growth of HT-29 human colon cancers in nude mice显示文摘	Radulovic S Schally AV	1994	Acta oncologicd1994，33，6：	2
4	Inhibitory effect of bombesin gastrin releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters 显示文摘	Szepeshazi K Schally AV Cai RZ	1991	Cancer Res1991，51，3：	2
5	Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice显示文摘	Schally AV Varga JL	2001	J Clin Endocrinol Metab2001，86，5：	1
6	Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238 显示文摘	Plonowski A Schally A V Nagy A	2002	Int J Oncol2002，20，2：	1
7	Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hor- mone显示文摘	Halmos G Schally AV Varga JL	2000	Proc Natl Acad Sci U S A2000，97，10：	1
8	Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin,AN-238显示文摘	Schally AV Koppan M	2001	Cancer2001，92，5：	1
9	Expression ofneuropeptide hormone receptors in human adrenal tumors and celllines: antiproliferative effects of peptide analogues显示文摘	Ziegler CG Brown IW Schally AV	2009	PNAS2009，106，15：	1
10	Inhibition of Growth of Experimental Human Endometrial Cancer by an Antagonist of Growth Hormone-Releasing Hormone显示文摘	Engel Jorg B Keller Gunhild Schally Andrew V	2005	Joumal of Clinical Endocrinology&Metabolism2005，90，6：	1
11	Human ovarian cancersexpress somatostatin receptors显示文摘	Halmos G Sun B Schally AV	2000	J Clin Endocrinol Metab2000，85，10：	1
12	Prac Soc Exp Biol Med显示文摘	Schally AV	1998	217(2):143-1521998，217，2：	1
13	The LHRH antagonist cetrorelix:a review显示文摘	Reissmann T Schally AV Bouchard P	2000	Hum Reprod Update2000，6，4：	1
14	Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis显示文摘	Schally AV Guillermet J Saint-Laurent N	2003	Proc Natl Acad Sci U S A2003，100，1：	1
15	Student learning by research显示文摘	Schallies M Lembens A	2002	J Biol Edu2002，37，：	1
16	Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway显示文摘	Rekasi Z Czompoly T Schally AV	2005	Proc Natl Acad Sci U S A2005，102，9：	1
17	New Approaches to the Therapy of Various Tumors Based on Peptide Analogues显示文摘	A. Schally	2008	Horm Metab Res2008，，：	1
18	Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215 显示文摘	Engle JB Keller G Schally AV	2005	Clin Cancer Res2005，11，6：	1
19	The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers显示文摘	Schally AV Zarandi M	2007	Prostate2007，67，12：	1
20	Inhibition of theUCI-107 human ovarian carcinoma cell line by a targetedcytotoxic analog of somatostatin,AN-238显示文摘	Plonowski A Schally AV Koppan M	2001	Cancer2001，92，5：	1

返回顶部每页显示：

共19页首页上一页第1页下一页末页 /19 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示